FTC approves UnitedHealth’s $4.3bn acquisition of DaVita Medical

23-08-2019

Saman Javed

FTC approves UnitedHealth’s $4.3bn acquisition of DaVita Medical

parbradyphoto / iStockphoto.com

The US Federal Trade Commission (FTC) has approved a final order settling charges that healthcare company UnitedHealth’s $4.3 billion acquisition of DaVita Medical would harm competition.


US Federal Trade Commission, Da Vita Medica, unfair competition, Medicare Advantage, insurance

LSIPR